v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sales:        
Total sales $ 14,398 $ 15,448 $ 42,446 $ 44,265
Cost of sales:        
Total cost of sales 10,065 10,995 28,906 31,041
Gross profit 4,333 4,453 13,540 13,224
Operating expenses:        
Research and development 832 791 2,508 2,340
Selling, general and administrative 5,043 4,885 13,537 13,455
Total operating expenses 5,875 5,676 16,045 15,795
Operating loss (1,542) (1,223) (2,505) (2,571)
Other income (expense):        
Foreign exchange gain (loss) (23) (200) 40 (37)
Interest expense (182) (105) (477) (259)
Interest income 524 440 1,652 1,343
Other income, net 11 73 145 75
Total other income, net 330 208 1,360 1,122
Loss before income taxes (1,212) (1,015) (1,145) (1,449)
Income tax benefit (366) (751) (654) (1,549)
Net income (loss) (846) (264) (491) 100
Net income (loss) attributable to common shareholders $ (846) $ (264) $ (491) $ 94
Net income (loss) per common share - basic (in dollars per share) $ (0.09) $ (0.03) $ (0.05) $ 0.01
Weighted average common shares outstanding - basic (in shares) 9,560 9,362 9,494 9,275
Net income (loss) per common share - diluted (in dollars per share) $ (0.09) $ (0.03) $ (0.05) $ 0.01
Weighted average common shares outstanding - diluted (in shares) 9,560 9,362 9,494 9,611
Product        
Sales:        
Total sales $ 9,943 $ 10,150 $ 27,757 $ 29,717
Cost of sales:        
Total cost of sales 7,890 8,553 22,570 24,551
Service        
Sales:        
Total sales 4,455 5,298 14,689 14,548
Cost of sales:        
Total cost of sales $ 2,175 $ 2,442 $ 6,336 $ 6,490